Literature DB >> 17701359

Myeloperoxidase binds to non-vital spermatozoa on phosphatidylserine epitopes.

Jacqueline Lessig1, Holger Spalteholz, Uta Reibetanz, Pavel Salavei, Martin Fischlechner, Hans-Jürgen Glander, Jürgen Arnhold.   

Abstract

The heme protein myeloperoxidase is released from stimulated polymorphonuclear leukocytes, a cell species found in increasing amounts in the male and female genital tract of patients with genital tract inflammations. Myeloperoxidase binds only to a fraction of freshly prepared human spermatozoa. The number of spermatozoa able to bind myeloperoxidase raised considerably in samples containing pre-damaged cells or in acrosome-reacted samples. In addition, myeloperoxidase released from zymosan-stimulated polymorphonuclear leukocytes was also able to bind to pre-damaged spermatozoa. The ability of spermatozoa to bind myeloperoxidase coincided with the binding of annexin V to externalized phosphatidylserine epitopes indicating the loss of plasma membrane integrity and with the incorporation of ethidium homodimer I. Myeloperoxidase did not interact with intact spermatozoa. Annexin V and myeloperoxidase bind to the same binding sites as verified by double fluorescence techniques, flowcytometry analyses as well as competition experiments. We demonstrated also that myeloperoxidase is eluted together with pure phosphatidylserine liposomes or liposomes composed of phosphatidylserine and phosphatidylcholine in gel filtration, but not with pure phosphatidylcholine liposomes. In conclusion, myeloperoxidase interacts with apoptotic spermatozoa via binding to externalized phosphatidylserine indicating a yet unknown role of this protein in recognition and removal of apoptotic cells during inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701359     DOI: 10.1007/s10495-007-0113-5

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

1.  Surface-bound myeloperoxidase is a ligand for recognition of late apoptotic neutrophils by human lung surfactant proteins A and D.

Authors:  Anne Jäkel; Howard Clark; Kenneth B M Reid; Robert B Sim
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

2.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation.

Authors:  Valerian E Kagan; Nagarjun V Konduru; Weihong Feng; Brett L Allen; Jennifer Conroy; Yuri Volkov; Irina I Vlasova; Natalia A Belikova; Naveena Yanamala; Alexander Kapralov; Yulia Y Tyurina; Jingwen Shi; Elena R Kisin; Ashley R Murray; Jonathan Franks; Donna Stolz; Pingping Gou; Judith Klein-Seetharaman; Bengt Fadeel; Alexander Star; Anna A Shvedova
Journal:  Nat Nanotechnol       Date:  2010-04-04       Impact factor: 39.213

3.  Human sperm quality and lipid content after migration into normal ovulatory human cervical mucus containing low numbers of leukocytes.

Authors:  Nozha Chakroun-Feki; Patrice Therond; Martine Couturier; Florence Eustache; Gerard Limea; Alain Legrand; Pierre Jouannet; Jacques Auger
Journal:  Asian J Androl       Date:  2009-02-02       Impact factor: 3.285

4.  Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.

Authors:  Richard A Maki; Vladimir A Tyurin; Robert C Lyon; Ronald L Hamilton; Steven T DeKosky; Valerian E Kagan; Wanda F Reynolds
Journal:  J Biol Chem       Date:  2008-12-05       Impact factor: 5.157

Review 5.  Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins.

Authors:  Jenny Schröter; Jürgen Schiller
Journal:  Oxid Med Cell Longev       Date:  2016-12-20       Impact factor: 6.543

6.  Removal of spermatozoa with externalized phosphatidylserine from sperm preparation in human assisted medical procreation: effects on viability, motility and mitochondrial membrane potential.

Authors:  Corinne de Vantéry Arrighi; Hervé Lucas; Didier Chardonnens; Ariane de Agostini
Journal:  Reprod Biol Endocrinol       Date:  2009-01-08       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.